Physician

John K Randall, RPH, MD

According to 2025 Medicare claims, John Randall, RPH, MD (NPI: 1326076530) practices micrographic dermatologic surgery in the Lafayette-West Lafayette, IN market, with the plurality of this provider's patient population coming from Tippecanoe, IN. This provider's primary affiliated billing organization is RANDALL DERMATOLOGY, PC (NPI: 1245340488; TIN: 35-2033893) and primary practice location at 47906-1569. Randall is affiliated with the Franciscan ACO, Inc. (ACO ID: A2550), Ascension Care Management (ACO ID: A2600), CHSPSC ACO 2, LLC (ACO ID: A3664), and Main Street Rural Health Sycamore ACO LLC (ACO ID: A5403), participating under the MSSP model.

Randall's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,360 traditional Medicare patients, billed 16,857 HCPCS/CPT codes, and received $1,673,452 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 976 prescription claims across 391 beneficiaries totaling $1,048,687 in drug costs, led by Erivedge (Vismodegib). Open Payments data shows 148 records totaling $228,731. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $113,601 to $1,048,687. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,178	11,750	$1,188,939
2016	1,233	11,397	$1,268,935
2017	1,252	10,228	$1,256,019
2018	1,274	13,981	$1,494,203
2019	1,360	15,843	$1,631,010
2020	1,219	15,087	$1,464,148
2021	1,260	16,100	$1,605,193
2022	1,314	15,388	$1,572,427
2023	1,323	15,801	$1,489,757
2024	1,360	16,857	$1,673,452

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	138	277	$113,601
2016	179	375	$149,898
2017	173	344	$91,387
2018	179	346	$208,083
2019	211	457	$278,165
2020	198	386	$157,219
2021	311	624	$448,893
2022	300	693	$484,609
2023	359	852	$839,471
2024	391	976	$1,048,687

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	514	636	$72
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	627	883	$58
99212	Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more	328	526	$39
17000	Destruction of precancer skin growth, 1 growth	801	1,156	$36
17003	Destruction of precancer skin growth, 2-14 growths	649	3,687	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erivedge	Vismodegib	28	834	$405,051
Cosentyx Sensoready (2 Pens)	Secukinumab	22	616	$163,237
Otezla	Apremilast	15	450	$77,030
Santyl	Collagenase Clostridium Hist.	15	411	$20,395
Tavaborole	Tavaborole	15	450	$6,181

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	78	$1,024	Novartis Pharmaceuticals Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	70	$227,707	ABBVIE INC.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John K. Randall, RPH, MD?

Tedicare shows public-source Medicare data for John K. Randall, RPH, MD (NPI 1326076530), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John K. Randall, RPH, MD have ACO affiliation data?

John K. Randall, RPH, MD is shown with ACO affiliation data for Franciscan ACO, Inc. (MSSP, ACO ID A2550), Ascension Care Management (MSSP, ACO ID A2600), CHSPSC ACO 2, LLC (MSSP, ACO ID A3664), and Main Street Rural Health Sycamore ACO LLC (MSSP, ACO ID A5403).

What billing organization is linked to John K. Randall, RPH, MD?

John K. Randall, RPH, MD is linked to RANDALL DERMATOLOGY, PC (billing NPI 1245340488) in the available physician profile data.

Does John K. Randall, RPH, MD have Open Payments data?

John K. Randall, RPH, MD has 148 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.